tm2612770-1_424b7 - none

424B7 1 tm2612770-1_424b7.htm 424B7 tm2612770-1_424b7 - none - 7.7969353s

Filed Pursuant to Rule 424(b)(7)

Registration No. 333-281084

PROSPECTUS SUPPLEMENT
(To Prospectus dated July 29, 2024)

95,876,547 Shares of Common Stock
192,533 Shares of Series C Convertible Perpetual Preferred Stock

This prospectus supplement relates to the resale by the selling stockholders identified in this prospectus supplement (the “selling stockholders”) of (i) 95,876,547 shares of common stock, par value $0.00001 per share (“common stock”), of QXO, Inc. (“QXO” or the “Company”), which includes (A) 13,066,710 shares of common stock outstanding and (B) 82,809,837 shares of common stock issuable upon conversion of shares of Series C Preferred Stock (as defined below), and (ii) 192,533 shares of Series C Convertible Preferred Stock of the Company, par value $0.001 per share (the “Series C Preferred Stock”). We will not receive any proceeds from the sale of the shares offered by this prospectus supplement.

The selling stockholders may sell the shares on any national shares exchange or quotation service on which the shares may be listed or quoted at the time of sale, on the over-the-counter market, in one or more transactions otherwise than on these exchanges or systems, such as privately negotiated transactions, or using a combination of these methods, and at fixed prices, at prevailing market prices at the time of the sale, at varying prices determined at the time of sale, or at negotiated prices. See “Plan of Distribution” for more information about how the selling stockholders may sell or otherwise dispose of their shares hereunder.

The selling stockholders may sell any, all or none of the shares offered by this prospectus supplement and we do not know when or in what amounts the selling stockholders may sell their shares hereunder.

Our common stock is listed on the New York Stock Exchange (the “NYSE”) under the symbol “QXO.” On April 28, 2026, the last reported sale price of our common stock on the NYSE was $19.61 per share.

See “Risk Factors” beginning on page S-4 of this prospectus supplement and in the documents incorporated by reference in this prospectus supplement to read about factors you should consider before buying our shares.

Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of these shares or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

Prospectus Supplement dated April 29, 2026.

	Page
ABOUT THIS PROSPECTUS SUPPLEMENT		S-ii
MARKET AND INDUSTRY INFORMATION		S-iii
TRADEMARKS AND TRADE NAMES		S-iii
WHERE YOU CAN FIND MORE INFORMATION		S-iii
INCORPORATION BY REFERENCE		S-iv
FORWARD-LOOKING STATEMENTS		S-v
SUMMARY		S-1
RISK FACTORS		S-4
USE OF PROCEEDS		S-9
SELLING STOCKHOLDERS		S-10
PLAN OF DISTRIBUTION		S-19
LEGAL MATTERS		S-21
EXPERTS		S-21

	Page
ABOUT THIS PROSPECTUS		1
WHERE YOU CAN FIND MORE INFORMATION		1
INCORPORATION BY REFERENCE		2
FORWARD-LOOKING STATEMENTS		3
THE COMPANY		4
RISK FACTORS		5
SELECTED FINANCIAL DATA		6
USE OF PROCEEDS		8
DESCRIPTION OF CAPITAL STOCK		9
DESCRIPTION OF THE DEBT SECURITIES		16
DESCRIPTION OF DEPOSITARY SHARES		25
DESCRIPTION OF THE WARRANTS		28
DESCRIPTION OF THE RIGHTS		30
DESCRIPTION OF THE PURCHASE CONTRACTS		31
DESCRIPTION OF THE UNITS		32
SELLING SECURITYHOLDERS		33
PLAN OF DISTRIBUTION		34
LEGAL MATTERS		37
EXPERTS		37

	Common Stock Owned Prior to the Offering(1)				Number of Shares Offered		Common Stock Owned After the Offering(2)
Name of Selling Stockholder	Shares		%		Number of Shares Offered		Shares		%
AP Quince Holdings(3)		28,473,118		3.9%		28,473,118		—		—
Entities affiliated with Finepoint Capital LP(4)		16,295,834		2.3%		2,437,419		13,858,415		1.9%
Entities managed by Franklin Advisers, Inc.(5)		14,368,843		2.0%		8,602,150		5,766,693		1.0%
Maniro Limited(6)		13,808,445		1.9%		2,867,526		10,940,919		1.5%
Cypress Holdco I, LLC(7)		12,194,359		1.7%		1,720,430		10,473,929		1.4%
Entities affiliated with Court Square Capital Partners(8)		9,315,689		1.3%		9,315,689		—		—
Blue Investment Group(9)		9,220,134		1.3%		1,147,096		8,073,038		1.1%
Entities managed by PGIM, Inc.(10)		7,885,152		1.1%		7,885,152		—		—
Entities affiliated with Patient Capital Management, LLC(11)		7,638,604		1.1%		860,215		6,778,389		*
Whitecap Investments Pte. Ltd.(12)		7,168,602		1.0%		7,168,602		—		—
Forest Avenue Capital Management LP(13)		4,751,171		*		143,655		4,607,516		*
Bryde Investment Limited Partnership(14)		4,301,075		*		4,301,075		—		—
Federated Hermes Kaufmann Funds(15)		3,880,931		*		573,331		3,307,600		*

	Common Stock Owned Prior to the Offering(1)				Number of Shares Offered		Common Stock Owned After the Offering(2)
Name of Selling Stockholder	Shares		%		Number of Shares Offered		Shares		%
Entities affiliated with Eaton Vance(16)		2,723,864		*		2,723,864		—		—
Entities affiliated with Monarch Alternative Capital LP(17)		2,437,417		*		2,437,417		—		—
Alberta Investment Management Corporation(18)		2,378,366		*		2,007,311		371,055		*
Entities affiliated with Loomis, Sayles & Company, L.P.(19)		1,433,976		*		1,433,976		—		—
Ensign Peak Advisors, Inc.(20)		1,346,232		*		860,215		486,017		*
Entities affiliated with Sona Asset Management (US) LLC(21)		716,989		*		716,989		—		—
RMO 2 LLC(22)		697,841		*		697,841		—		—
Diameter Dislocation Master Fund III(23)		573,763		*		573,763		—		—
Entities affiliated with Liberty Mutual Holding Company, Inc.(24)		573,333		*		573,333		—		—
ClearBridge Investments, LLC(25)		573,333		*		573,333		—		—
Major Tom Private Capital LLC(26)		573,333		*		573,333		—		—
Henderson Institute For Public Policy, Inc.(27)		573,333		*		573,333		—		—
LVB Holdings SAM(28)		430,108		*		430,108		—		—
All Other Selling Stockholders(29)		7,011,597		*		6,636,387		375,210		*

	Year Ended December 31,
	2023			2022			2021
Basic net loss per share computation:
Net loss		$	(1,070,095)		$	(282,219)		$	(134,434)
Weighted-average common shares outstanding			5,259,595			5,167,081			5,026,420
Basic net loss per share		$	(0.20)		$	(0.05)		$	(0.03)
Diluted net loss per share computation:
Net loss per above		$	(1,070,095)		$	(282,219)		$	(134,434)
Weighted-average common shares outstanding			5,259,595			5,167,081			5,026,420
Incremental shares for convertible promissory note warrants and stock options(1)			—			—			—
Diluted net loss per share		$	(0.20)			(0.05)		$	(0.03)
Shares of common stock issued and outstanding at year end			5,315,581			5,256,177			5,136,177

	Three Months Ended
	March 31, 2024			September 30, 2023			June 30, 2023			March 31, 2023			September 30, 2022			June 30, 2022			March 31, 2022
Basic net income per share computation:
Net income		$	138,087		$	(2,110,178)		$	343,361		$	277,491		$	(134,237)		$	(87,766)		$	(40,656)
Weighted-average common shares outstanding			5,315,581			5,256,177			5,256,177			5,256,177			5,136,177			5,136,177			5,136,177
Basic net income per share		$	0.03		$	(0.40)		$	0.07		$	0.05		$	(0.03)		$	(0.02)		$	(0.01)
Diluted net income per share computation:
Net income per above		$	138,087		$	(2,110,178)		$	343,361		$	277,491		$	(134,237)		$	(87,766)		$	(40,656)
Weighted-average common shares outstanding			5,315,581			5,256,177			5,256,177			5,256,177			5,136,177			5,136,177			5,136,177
Total adjusted weighted-average shares			5,315,581			5,256,177			5,256,177			5,256,177			5,136,177			5,136,177			5,136,177
Diluted net income per share		$	0.03		$	(0.40)		$	0.07		$	0.05		$	(0.03)		$	(0.02)		$	(0.01)
Shares of common stock issued and outstanding at period end			5,315,581			5,256,177			5,256,177			5,256,177			5,136,177			5,136,177			5,136,177

SEC Form 424B7 filed by QXO Inc.